Gyre Therapeutics, Inc.
GYRE
Revenue
30.56M
▲3.79M▲14.17%
3 Months ChangeAssets
159.38M
▲6.74M▲4.41%
3 Months ChangeLiabilities
21.97M
▼-1.23M▼-5.32%
3 Months ChangeFree Cash Flow
-251.00k
▼-2.90M▼-109.46%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-02
Form 8-K
ID: 0001140361-26-007249
2026-01-05
Form 8-K
ID: 0001140361-26-000253
2025-11-07
Form 10-Q
ID: 0001193125-25-272383
2025-11-07
Form 8-K
ID: 0001193125-25-270524
2025-09-10
Form 8-K
ID: 0001140361-25-034506
2025-08-22
Form 8-K
ID: 0001140361-25-032295
2025-08-11
Form 10-Q
ID: 0000950170-25-106644
2025-08-11
Form 8-K
ID: 0000950170-25-106525
2025-06-06
Form 8-K
ID: 0001140361-25-021612
2025-05-23
Form 8-K
ID: 0001140361-25-020353